Given the significance of the JNK/c-Jun signaling pathway in AML, our research provided novel insights that Nrf2 inhibited MSH2 expression and promoted AML gene instability-dependent chemoresistance by activating the JNK/c-Jun signaling pathway (Fig. 7). Here, NFE2L2 is linked to acute myeloid leukemia.